Aravive Q3 EPS $(0.53) Up From $(0.66) YoY

Aravive (NASDAQ:ARAV) reported quarterly losses of $(0.53) per share. This is a 19.7 percent increase over losses of $(0.66) per share from the same period last year.

byBenzinga Newsdesk

October 28, 2021

1 minute read

Aravive (NASDAQ:ARAV) reported quarterly losses of $(0.53) per share. This is a 19.7 percent increase over losses of $(0.66) per share from the same period last year.

BMO Capital Maintains Outperform on IAC/InterActiveCorp, Lowers Price Target to $173

By Benzinga Newsdesk

Today, 2:30 AM

BMO Capital analyst Daniel Salmon maintains IAC/InterActiveCorp (NASDAQ:IAC) with a Outperform and lowers the price target from $195 to $173.

IAC

Why This Entertainment Company Could Be An Acquisition Target For Streaming Giants Amazon, Apple Or Netflix

By Robert Kuczmarski

Today, 2:30 AM

Lions Gate Entertainment Corporation (NYSE: LGF-A) (NYSE: LGF-B) is a film entertainment studio with a presence in motion pictures, television programming, home entertainment, and digitally delivered content.

AAPL

Events
News

Wave Life Sciences Highlights Therapeutic Potential For WVE-006 For Alpha-1 Antitrypsin Deficiency And Progress Bringing RNA Editing To The Clinic During Analyst And Investor Event

By Benzinga Newsdesk

Today, 2:30 AM

WVE-006 is the most advanced candidate for AATD designed to restore functional wild-type AAT protein and reduce Z-AAT protein aggregation with potential for disease modification in both lung and liver

WVE

Mid-Morning Market Update: Markets Edge Lower; Designer Brands Earnings Top Estimates

By Lisa Levin

Today, 2:30 AM

Following the market opening Tuesday, the Dow traded down 0.04% to 35,387.11 while the NASDAQ fell 0.30% to 15,219.57. The S&P also fell, dropping 0.12% to 4,523.41.

ACIU

Aravive Q3 EPS $(0.53) Up From $(0.66) YoY

Related Posts

BMO Capital Maintains Outperform on IAC/InterActiveCorp, Lowers Price Target to $173

Why This Entertainment Company Could Be An Acquisition Target For Streaming Giants Amazon, Apple Or Netflix

Wave Life Sciences Highlights Therapeutic Potential For WVE-006 For Alpha-1 Antitrypsin Deficiency And Progress Bringing RNA Editing To The Clinic During Analyst And Investor Event

Mid-Morning Market Update: Markets Edge Lower; Designer Brands Earnings Top Estimates